The DOI matches its Crossref record.
Epidemiological Analysis of Alcohol and Drug Use as Risk Factors for Psychotic Experiences
Abstract
Clinical and laboratory studies link alcohol and other drug use to the occurrence of psychotic experiences, but epidemiologic evidence has been lacking. In this study, the quantitative relationships between alcohol or other drug use and psychotic experiences were examined by analysis of prospective data from 4994 adult household residents sampled in a multisite survey of mental disorders in the population, the NIMH Epidemiologic Catchment Area Program. After control for sociodemographic factors and preexisting psychiatric conditions, the risk for onset of self-reported delusions or hallucinations was observed to be greater for daily users of marijuana or cocaine and for users of anxiolytics or sympathomimetics compared with nonusers. After control for daily cocaine use and alcohol disorder, the risk of onset of psychotic experiences for daily users of marijuana was double that for nonusers. Alcohol disorder in men was associated with eightfold risk and in women with threefold risk. Baseline depressive episodes, manic episodes, agoraphobia, and obsessive-compulsive disorder also were associated with increased risk of onset of psychotic experiences. — J Nerv Ment Dis 178:473-480, 1990
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the ECA study (20) daily cannabis use was associated with increased risk of psychotic experiences, although there was little evidence that ever use of cannabis was associated with these experiences.”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [20]
In the citing paper
“In the ECA study (20) daily cannabis use was associated with increased risk of psychotic experiences, although there was little evidence that ever use of cannabis was associated with these experiences.”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [20]
In the citing paper
“| ECA (20) | 2295 | Daily use of | Psychotic | 2.0 | Large sample | No |”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [20]
Citations
Cited by
Sorted by citations
Items 101–141 of 141
Is there sufficient evidence that cannabis use is a risk factor for psychosis?
Colizzi, M., & Bhattacharyya, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00016-8 · Cited by 11
Serotonin 2A receptors and cannabinoids
Ibarra‐Lecue, I., Dı́ez-Alarcia, R., & Urigüen, L. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.004 · Cited by 11
The Association Between Cannabinoids and Psychosis
Tikka, S. K., & D’Souza, D. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_14 · Cited by 10
Johnstad, P. G. (2022) · Drug Science Policy and Law · doi:10.1177/20503245221095228 · Cited by 12
Environmental Risk Factors for Schizophrenia
McGrath, J. J., & Murray, R. M. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch11 · Cited by 10
Impact of Substance Use Disorder on Presentation of Schizophrenia
Chaudhury, S., Tikka, S. K., & Bakhla, A. K. (2016) · Dual Diagnosis Open Access · doi:10.21767/2472-5048.100007 · Cited by 9
Marijuana Use in the Era of Changing Cannabis Laws: What Are the Risks? Who is Most at Risk?
Stoecker, W. V., Rapp, E. E., & Malters, J. M. (2018) · Europe PMC (PubMed Central) · Cited by 8
Schizophrénie et cannabinoïdes
Potvin, S., Stip, É., & Roy, J.-Y. (2004) · Drogues santé et société · doi:10.7202/008536ar · Cited by 8
Zerdazi, E., Curis, E., Karsinti, E., Icick, R., Fortias, M., Batel, P., Cottencin, O., Orizet, C., Gay, A., Coeuru, P., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109270 · Cited by 7
Pani, P., Maremmani, A. G. I., Pacini, M., Trogu, E., Gessa, G. L., Ruiz, P., & Maremmani, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061913 · Cited by 6
Legalization of Recreational Cannabis: Is India Ready for it?
Chithra, N. K., Bojappen, N., Vajawat, B., Pai, N. M., Gowda, G. S., Moirangthem, S., Kumar, C. N., & Math, S. B. (2023) · Indian Journal of Social Psychiatry · doi:10.4103/ijsp.ijsp_171_21 · Cited by 6
Hall, W., Degenhardt, L. J., & Patton, G. C. (2008) · Elsevier eBooks · doi:10.1016/b978-012373625-3.50006-1 · Cited by 6
Cannabis use and psychosis: the origins and implications of an association
Macleod, J. (2007) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.106.003434 · Cited by 6
Eykur notkun kannabis hættu á geðrofi og þróun geðklofa?
Jonsson, A. J., Birgisdóttir, H., Sigurðsson, E., & Sigurðsson, E. (2014) · Læknablaðið · doi:10.17992/lbl.2014.09.556 · Cited by 8
Kann Cannabis das Risiko für schizophrene Psychosen erhöhen?
Bugra, H., Rapp, C., Studerus, E., Aston, J., Borgwardt, S., & Riecher‐Rössler, A. (2012) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0032-1325415 · Cited by 5
Comorbidity of Substance Abuse and Psychotic Disorders: Focus on Adolescents and Young Adults
Milin, R. (1996) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30388-2 · Cited by 5
Cannabis as a causal factor for psychosis — a review of the evidence
Witton, J., Arseneault, L., Cannon, M. D., & Murray, R. M. (2004) · Steinkopff eBooks · doi:10.1007/978-3-7985-1953-4_9 · Cited by 4
Hambrecht, M., & Häfner, H. (2002) · doi:10.1002/9780470713846.ch2 · Cited by 4
The interaction of alcohol and cocaine: A review
Dial, J. (1992) · Psychobiology · doi:10.3758/bf03332045 · Cited by 4
Cannabis and Psychosis: A Review of the Risk Factors Involved
Amar, M. B. (2020) · American Journal of Plant Sciences · doi:10.4236/ajps.2020.1112139 · Cited by 3
Cross-Sectional Descriptive Pilot Study on the Risk of Psychotic Disorders among Adolescents
Cendrero-Luengo, C., Jiménez-Palomares, M., Rodríguez-Mansilla, J., & Garrido-Ardila, E. M. (2021) · Children · doi:10.3390/children8100916 · Cited by 3
Does cannabis use cause schizophrenia? The epidemiological evidence
Zammit, S., Arseneault, L., & Murray, R. M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.016 · Cited by 3
Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population
Solowij, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00005-7 · Cited by 3
Komorbidität von Substanzabhängigkeitsstörungen und anderen psychischen Störungen
Maier, W., Linz, M., & Freyberger, H. J. (1997) · Springer eBooks · doi:10.1007/978-3-642-45764-7_5 · Cited by 3
Guerrero, C. L., Castro-Martínez, J. A., Duque, L. C., et al. (2017) · Drugs and Addictive Behavior · doi:10.21501/24631779.2443 · Cited by 2
Sharma, V., Garg, S., Sharma, D. D., Chauhan, A., & Sharma, M. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20202259 · Cited by 2
Substance-induced psychosis: an overview
Thirthalli, J., Benegal, V., & Gangadhar, B. N. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511789977.009 · Cited by 2
Cannabis and Psychosis: Correlation, Causality, and Consequences
Basu, D., & Parakh, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00048-x · Cited by 2
Tryggedsson, J. S. J., Andersen, K., Nielsen, A. S., Olsen, C. D. H., & Mellentin, A. I. (2025) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2025.209793 · Cited by 1
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50044-8 · Cited by 1
Cannabis and Neuropsychiatric Effects
Rettew, D. C., Gundersen, D. C., Rapp, E. K., Riggs, P., Miller, C. L., Jackson, M., Sabet, K. A., Cort, B., & Bader, L. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_4 · Cited by 1
Socio-Demographic Characteristics of the Psychiatric Population with Comorbid Alcoholism
Drăgoi, A. M., Trifu, A. I., & Trifu, S. (2020) · Revista de Cercetare si Interventie Sociala · doi:10.33788/rcis.70.16 · Cited by 1
Understanding Psychiatric Comorbidities and Addictions
Anthony, J. C. (2013) · doi:10.1002/9781118384404.ch4 · Cited by 1
Self-citationNeglect of Legal Statute Influence on Health Outcomes in Studies about Human Cannabis UsePreprint
Moulin, T. C., Alves, J. A. J., & de Menezes, J. R. L. (2020) · Preprints.org · doi:10.20944/preprints202009.0417.v1
Psychological and Psychiatric Consequences of Cannabis
Phariss, B., Millman, R. B., & Beeder, A. B. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2913-9_10
Malchow, B. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4033
Molecular mechanisms underlying cannabis-induced risk of psychosis
Unzueta‐Larrinaga, P., Callado, L. F., & Urigüen, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823490-7.00004-6
Psychotic-like experiences and problem drinking among adults in Japan
Stickley, A., Shirama, A., & Sumiyoshi, T. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111319
Patel, K., Kim, S., Liu, K., Pathak, S., Nadar, R. M., Parise, R., Sridhar, S. B., Shareef, J., Alharbi, H. F., DeRuiter, J., et al. (2024) · Nutritional neurosciences · doi:10.1007/978-981-97-2577-9_10
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-816791-5.00001-7
Cannabis: A Clue or a Distraction in the Search for ‘Causes’ of Psychosis?
McGrath, J. J., & Degenhardt, L. J. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0913-8_20
Metadata
- Authors
- TIEN, A. Y., & ANTHONY, J. C.
- Affiliations
- Johns Hopkins University (US)
- Venue
- The Journal of Nervous and Mental Disease
- Published
- 1990-08
- Volume
- 178
- Issue
- 8
- Pages
- 473-480
- ISSN
- 0022-3018 (ISSN-L)
- OpenAlex
- W2019502220
- Cited by
- 175
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 9 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 5
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Nervous and Mental Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh041908-04, 5r01da003992-04)
- National Institute of Mental Health (MH41908, MH-14592, T32MH014592)
- National Institute on Drug Abuse (DA03992)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- alcohol consumption, drug use, psychotic experiences, delusions, hallucinations, cannabis, cocaine, anxiolytics, sympathomimetic drugs, alcohol-related disorders, substance use risk factors, depressive episodes, manic episodes, agoraphobia, obsessive-compulsive disorder
- MeSH terms
- Alcoholism, Mental Disorders, Marijuana Abuse, Cocaine, Delusions, Epidemiologic Methods, Hallucinations, Humans, Prospective Studies, Psychiatric Status Rating Scales, Psychotic Disorders, Risk Factors, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
